Tata Elxsi shares down by 5% after disappointing Q4 results

Tata Elxsi's shares dropped 5% to Rs 7,000 today as investors were disappointed by the company's Q4 results. The company reported a 4.5% sequential decline in net profit in its quarterly results announced yesterday. Q4 revenue stood at Rs 905.9 crore, down 0.9% QoQ, marking the first sequential revenue decline since Q1 of FY21.

Shares of today dipped 5% to the day’s low of Rs 7,000 after the Q4 results of the company disappointed the investors. The company announced its quarterly results yesterday wherein it posted a decline of 4.5% sequentially in its net profit.

The engineering service provider saw its Q4 revenue at Rs 905.9 crore, down 0.9% quarter-on-quarter (QoQ). This is the first time after Q1 of FY21 that the company has seen a sequential revenue decline. For the full fiscal its revenue grew by 13% on-year to Rs 3,552 crore.

Tata Elxsi said that it was impacted by its media and communication vertical which declined by 4.6% in constant currency (CC) terms in Q4 and saw a one-time ramp-down by a customer.

While attrition fell by 50 bps to 12.4% in Q4 from 12.9% in Q3, the company’s headcount increased by 178 to end the year at 13,399. It said 25% of its entire talent base will be AI-ready by Q3 FY25. It has partnered with NVIDIA, AWS, Microsoft, Google, Intel, and Brainchip.

Here’s what brokerages have to say on the stock:

Morgan Stanley

Morgan Stanley has an underweight call on Tata Elxsi with a target price of Rs 6,860 and said the March quarter was a miss but the management sounded constructive on revenue growth in FY25. However, good commentary may not be enough given burden of higher expectations and steep valuations, it said while reducing EPS estimates for FY25-26 to 3.9% and 5.4%

Choice Broking

Domestic broking firm Choice Broking has maintained a ‘buy’ call on Tata Elxsi with a revised target price of Rs 8,095, which signals an upside potential of 15% for the stock. The brokerage said that the management is committed to growth backed by strategic relationships built over the years with key customers, the qualitative change in revenues towards OEMs and SDV programs, entries into new operators and marquee healthcare logos, investments and talents in hiring, investments in strategic technology areas in AI and a strong deal pipeline.

Also read:

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Source: Stocks-Markets-Economic Times

Последние публикации
Australia regulator sues NAB for breach of financial hardship laws
18.11.2024 - 00:00
Peru, Japan strengthen ties with defense and mining agreements
18.11.2024 - 00:00
Carrots linked to one US death, 39 cases of illness from E. coli, CDC says
18.11.2024 - 00:00
Overheating issue could delay NVIDIA's new Blackwell AI servers – The Information
17.11.2024 - 23:00
Israel stocks higher at close of trade; TA 35 up 0.04%
17.11.2024 - 18:00
New Nvidia AI chips overheating in servers, the Information reports
17.11.2024 - 17:00
New Nvidia AI chips face issue with overheating servers, The Information reports
17.11.2024 - 16:00
Saudi Arabia stocks higher at close of trade; Tadawul All Share up 0.18%
17.11.2024 - 15:00
Russia resells more gas in Europe after cutting off Austria, sources, data show
17.11.2024 - 14:00
5 big analyst AI moves: Any Nvidia stock pullback is ‘an opportunity’
17.11.2024 - 11:00
Former employees share key contrasts between Amazon & Google
17.11.2024 - 10:00
Wells Fargo visited Tesla's GigaTexas factory. Here are the key takeaways
17.11.2024 - 10:00
Tata seals deal with Pegatron for iPhone plant in India's Tamil Nadu, sources say
17.11.2024 - 09:00
Warner Bros Discovery, NBA settle legal battle over broadcast rights, WSJ reports
17.11.2024 - 05:00
Netflix says 60 million households worldwide tuned in for Paul-Tyson match
17.11.2024 - 02:00

© Analytic DC. All Rights Reserved.

new
Анализ рынка Как повлият завтра отчет NFP на курс доллара США?